EUVIMED · CrossrefZeitschrift
Neurology and Therapy
ISSN 2193-6536 · Springer Science and Business Media LLC
Neueste Artikel
Total Economic Impact of Anti-Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder
Perceived Quality of Treatment Decisions and Determinants of Decisional Conflict in Early-Stage Relapsing–Remitting Multiple Sclerosis
Anxiety and Depression Symptoms During CGRP-Targeted Therapy in Patients with Migraine: A Retrospective Cohort Study from the United Arab Emirates
Long-Term Efficacy of Adjunctive Cenobamate by Focal Seizure Subtypes: Open-Label Extension of a Randomized Clinical Study in a Multinational Asian Population
Patient Preferences for Self-Administered Subcutaneous Immunoglobulin Therapy in Chronic Inflammatory Demyelinating Polyneuropathy
Cost-Effectiveness Analysis of Disease-Modifying Therapies for Early Alzheimer’s Disease in China
The Global Burden of Migraine: A Narrative Review and Expert Perspective on Disease Burden, Unmet Needs, and Policy Priorities
Concepts and Assessment of Fatigue in Myasthenia Gravis: A Scoping Review
Real-World Effectiveness and Tolerability of Rimegepant as Second- or Third-Line Acute Treatment for Migraine: A Prospective Observational Study
Optimizing the Use of Anti-CD20 Agents in Multiple Sclerosis and Other Autoimmune Central Nervous System Disorders: A Narrative Review
Migraine and Obesity: From Shared Mechanisms to Therapeutic Strategies
Comparative Evaluation of Rituximab Versus Approved Therapies in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Network Meta-analysis
Harnessing Brain Age-Specific Effects on the Associations Between Sleep Quality, Glymphatic Function, and Cognition in Normal Ageing Adults: Insights for Gerotherapeutics
Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-year Phase IV CLARIFY-MS Study
Treatment Characteristics and Healthcare Resource Utilization Among Patients with Myasthenia Gravis Initiating Rozanolixizumab: A US Claims Database Analysis
Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson's Disease: ROSSINI Study 6-Month Interim Results
Summary of Research: Cognition and Employment Status of People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-Year CLARIFY-MS Study
Prebiotics and SCFA Alleviate Parkinson’s-Related Constipation: Results from a Randomized Controlled Trial
Eculizumab in Myasthenia Gravis: A Multicenter Retrospective Real-World Study in China
Extended Preoperative Immunotherapy Duration Reduces the Risk of Myasthenia Gravis Exacerbation for Patients with Thymoma: A Multicenter Retrospective Cohort Study
Patient Perceptions of Needs and Expectations Regarding the Current Management of Myasthenia Gravis: A Biopsychosocial Study
Exploring Preferences and Priorities in Advanced Parkinson’s Disease: A Discrete Choice Experiment
Anti-aging and Anti-inflammatory Dietary Interventions in Multiple Sclerosis: A Narrative Review
Two-Year Outcomes Following Delandistrogene Moxeparvovec Treatment in Ambulatory Patients with Duchenne Muscular Dystrophy: Phase 3 EMBARK Trial
Venous Blood Cell Ratios as Predictors of Reperfusion Outcomes in Ischemic Stroke: A Systematic Review and Meta-analysis
Efgartigimod as an Add-on Therapy for Anti-IgLON5 Disease: A Case Report
Incorporating Patient Perspectives into a Composite Score for Measuring Disease Progression in Spinocerebellar Ataxia (SCA)
Foslevodopa/Foscarbidopa in Younger Patients Earlier Within Advanced Parkinson’s Disease: Post Hoc Analysis of a Randomized Trial
Association of Post-procedural Glucose with Clinical Outcomes After Endovascular Therapy for Large Vessel Occlusion
Real-World Experience with Anti-CGRP Pathway Monoclonal Antibodies in a Large United States Healthcare Plan: Results of the Migraine Signature Study
EUVIMED